Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000)

Clicks: 271
ID: 115565
2002
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
With reports of increasing resistance to antimicrobial agents among Pseudomonas aeruginosa clinical isolates worldwide, the activities of cefepime and eight other broad-spectrum beta-lactams against 6969 isolates collected during 1997-2000 from the four regions of the SENTRY Antimicrobial Surveillan …
Reference Key
rn2002diagnosticgeographic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jones RN;Kirby JT;Beach ML;Biedenbach DJ;Pfaller MA;;
Journal Diagnostic microbiology and infectious disease
Year 2002
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/12106958
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't population surveillance pseudomonas aeruginosa / drug effects* anti-bacterial agents / pharmacology pseudomonas infections / microbiology pseudomonas aeruginosa / isolation & purification fluoroquinolones global health anti-infective agents / pharmacology pmid:12106958 doi:10.1016/s0732-8893(02)00390-5 ronald n jones jeffrey t kirby michael a pfaller aminoglycosides cefepime ceftazidime / pharmacology cephalosporins / pharmacology beta-lactams / pharmacology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.